ストックスクリーナーアプリを入手
2.14
5.42%
0.11
アフターアワーズ：
2.14
前日終値:
$2.03
開ける：
$2.06
24時間の取引高:
191.19K
Relative Volume:
1.20
時価総額：
$93.34M
収益：
$106.79M
当期純損益:
$-8.73M
株価収益率:
-10.70
EPS:
-0.2
ネットキャッシュフロー:
$10.81M
1週間 パフォーマンス:
+8.08%
1か月 パフォーマンス:
-4.46%
6か月 パフォーマンス:
-22.74%
1年 パフォーマンス:
-56.94%
1日の値動き範囲:
$2.05
$2.185
1週間の範囲:
$1.953
$2.185
52週間の値動き範囲:
$1.95
$5.0759
Harvard Bioscience Inc Stock (HBIO) Company Profile
名前
Harvard Bioscience Inc
セクター
電話
(508) 893-8999
住所
84 OCTOBER HILL RD, HOLLISTON, MA
HBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
2.14 | 93.34M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-03-10 | アップグレード | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | アップグレード | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | 開始されました | Northland Capital | Outperform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | ダウングレード | Janney | Buy → Neutral |
| 2018-01-24 | 繰り返されました | Janney | Buy |
| 2018-01-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-11-17 | 開始されました | Singular Research | Buy |
| 2015-07-28 | 開始されました | The Benchmark Company | Buy |
すべてを表示
Harvard Bioscience Inc (HBIO) 最新ニュース
State Street Corp Acquires 7,763 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Nigeria
Lexaria Bioscience Forms Elite Scientific Advisory Board with Harvard Medical School Expert - StockTitan
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience - Yahoo Finance
BNP Paribas Financial Markets Has $201,000 Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
BNP Paribas Financial Markets Boosts Stock Position in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Update - Defense World
Harvard Bioscience (HBIO) Stock Dips Amid Industry Movements - GuruFocus.com
Harvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Harvard Bioscience (HBIO) Stock Drops Amid Market Volatility - GuruFocus.com
3 US Penny Stocks With Market Caps Under $100M - Simply Wall St
Harvard Bioscience files $100M mixed securities shelf - MSN
In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market TransformationTechnavio - The Malaysian Reserve
272 Capital LP Has $1.54 Million Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com
HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat
Ayla Majid becomes first South Asian ACCA president - The Accountant Online
Harvard Bioscience (HBIO) Stock Drops Amid Industry Downturn - GuruFocus.com
272 Capital LP Increases Stake in Harvard Bioscience Inc - GuruFocus.com
HBIO stock touches 52-week low at $2.29 amid market challenges - Investing.com India
Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Harvard Bioscience (HBIO) Stock Surges with Positive Analyst Rat - GuruFocus.com
Harvard Bioscience Inc (HBIO) Quarterly 10-Q Report - Quartzy
SEC Form 10-Q filed by Harvard Bioscience Inc. - Quantisnow
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Harvard Bioscience: Q3 Earnings Snapshot - CT Insider
Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
3 Promising US Penny Stocks With At Least $100M Market Cap - Simply Wall St
Harvard Bioscience Inc Reports Q3 2024 Revenue of $22.0M, Misses Estimates; EPS Loss of $0.11 - GuruFocus.com
Harvard Bioscience : Q32024 HBIO Quarterly Earnings Presentation - Marketscreener.com
Harvard Bioscience Announces Third Quarter 2024 Financial Results - GlobeNewswire
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: W - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance
Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance
Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Harvard Bioscience Inc (HBIO) 財務データ
収益
当期純利益
現金流量
EPS
Harvard Bioscience Inc (HBIO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Green James W | Chief Executive Officer |
Jun 06 '24 |
Buy |
3.07 |
20,000 |
61,400 |
3,101,091 |
2.64%
0.11%
大文字化:
|
ボリューム (24 時間):